Oxymorphone Hydrochloride 00115-1315
Product NDC
00115-1315- Manufacturer
- Amneal Pharmaceuticals Of New York Llc
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- January 2, 2013
- Listing Expires
- December 31, 2026
- Application
- ANDA079087
Active Ingredients
| Ingredient | Strength |
|---|---|
| Oxymorphone Hydrochloride | 7.5 mg/1 |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(4)
100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-01)
1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-03)
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-08)
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-13)